BILAXTEN ORAL SOLUTION 2.5MG/ML
Product details
Registration number: SIN15963P
Classification: Prescription Only
Active ingredients: BILASTINE
Strength: 2.5MG/ML
Dosage form: SOLUTION
Route: ORAL
Registrant: A. MENARINI SINGAPORE PTE. LTD.
ATC code: R06AX29
HSA approval date: 24 June 2020
Manufacturer(s): BERLIN-CHEMIE AG
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for BILAXTEN ORAL SOLUTION 2.5MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15963P
Classification: Prescription Only
What active ingredients and strength are recorded for BILAXTEN ORAL SOLUTION 2.5MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: BILASTINE
Strength: 2.5MG/ML
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for BILAXTEN ORAL SOLUTION 2.5MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: SOLUTION
Route: ORAL
Who is the recorded registrant for BILAXTEN ORAL SOLUTION 2.5MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: A. MENARINI SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for BILAXTEN ORAL SOLUTION 2.5MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): BERLIN-CHEMIE AG
Manufacturing country/countries: GERMANY
Where can I look up BILAXTEN ORAL SOLUTION 2.5MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15963P or the exact product name BILAXTEN ORAL SOLUTION 2.5MG/ML. The general register link does not preselect this product.
What are the source dates for this BILAXTEN ORAL SOLUTION 2.5MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this BILAXTEN ORAL SOLUTION 2.5MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15963P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)